ViiV releases promising phase 2 data on potential long-acting HIV drugs
Source: SeekingAlpha
2025-03-11 17:29:39 ET
More on GSK
- GSK plc (GSK) TD Cowen 45th Annual Health Care Conference (Transcript)
- GSK's Strong Performance: Why I'm Upgrading To 'Strong Buy'
- GSK Reported Strong Earnings, So I Reiterate My Strong Buy
- GSK shares rise for seven consecutive sessions
- CDC reports 58 new measles cases as nationwide count surpasses 200
Read the full article on Seeking Alpha
For further details see:
ViiV releases promising phase 2 data on potential long-acting HIV drugs
Shionogi & Co Ltd
NASDAQ: SGIOF
SGIOF Trading
0.0% G/L:
$23.105 Last:
800 Volume:
$25.373 Open:
